CHESTNUT RIDGE, N.Y., Sept. 10, 2020 /PRNewswire/ -- BioHiTech Global, Inc. ("BioHiTech" or the "Company") (NASDAQ: BHTG), a sustainable technology and services company, announced today its first lease contract for the Altapure AP-4™ high-level disinfectant technology to a K-12 public school district located in Pennsylvania (the "School District").
The School District will be utilizing the Altapure AP-4 as a part of its protocol to help protect the schools within the district from the spread of COVID-19 and potential infections from other viruses and bacteria. BioHiTech conducted two product demonstrations with representatives from the School District during the summer to show how the Altapure AP-4 achieves hospital-grade disinfection of classrooms, bathrooms and other common areas, including everything within the area such as toys, chromebooks, computers, rugs, carpeting, and sports equipment. BioHiTech expects to deliver the unit in the coming days and to conduct and broadcast a live demonstration with the School District at a ceremony to take place in the coming weeks.
"The implementation of the Altapure AP-4 with this School District is an important milestone for BioHiTech as we have achieved our first commercial success with this exciting new opportunity for our company," said Frank E. Celli, CEO of BioHiTech. "Education represents a very important market opportunity for us and we are confident other school districts around the nation will follow this district's leadership in creating a safer environment for learning. We all want our schools to reopen, but we want to make sure we are doing everything to keep our children and teachers as safe as possible when they are physically back in school. This system can be used as part of an ongoing cleaning protocol to periodically disinfect classrooms and equipment. It can also ensure that if a child or teacher tests positive for COVID-19, or some other virus, utilizing an automated process, school employees can quickly achieve a high-level disinfection of any potentially affected rooms to cut down on the chance of spread. We look forward to working with this customer in their important efforts to get students safely back to school and for other educational institutions to follow suit through our continued product demonstration and distribution efforts."
The Altapure AP-4™ is an enhanced, automated and touchless high-level disinfection sub-micron aerosol system launched in 2017, that provides a safe process and rapid kill of spores, viruses, and vegetative bacteria, such as but not limited to: COVID-19, Acinetobacter baumanii, Pseudomonas aeruginosa, VRE, MRSA, Bacillus atrophaeus, Geobacillus stearothermophilus, Polio virus, , C. auris and Clostridium difficile (C. difficile). Extensive research and development alongside Harris Corporation, formerly ITT Exelis, a top-tier global aerospace, defense, and information solutions company, resulted in the creation of a very unique and patented aerosol generation technology that when coupled with the liquid agent Altacare®, a reagent grade peracetic acid solution, yields rapid and unparalleled results for high level disinfection. Altapure is committed to providing its customers with the highest quality products and processes in the marketplace that are safe to use and are environmentally friendly. All of Altapure's products are engineered, manufactured, and assembled in the U.S.
About BioHiTech Global
BioHiTech Global, Inc. (NASDAQ: BHTG), is a technology services company focused on providing cost-effective solutions that improve environmental outcomes. Our technologies for waste management include the patented processing of municipal solid waste into a valuable renewable fuel, biological disposal of food waste on-site, and proprietary real-time data analytics tools to reduce food waste generation. When used individually or in combination, our solutions lower the carbon footprint associated with waste transportation and can reduce or virtually eliminate landfill usage. In addition, we distribute a patented technology that achieves high-level disinfection of spaces such as classrooms, hotel or hospital rooms and other enclosed areas to combat the spread of viruses and bacteria without the use of harsh chemicals. Our unique solutions enable businesses, educational institutions and municipalities of all sizes to solve everyday problems in a smarter and more cost-effective way while reducing their impact on the environment. For more information, please visit www.biohitech.com.
Forward Looking Statements
Statements in this press release contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Without limiting the foregoing, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "explore," "evaluate," "intend," "may," "might," "plan," "potential," "predict," "project," "seek," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These statements are also based on many assumptions and estimates and are not guarantees of future performance. These statements are estimates, based on information available to management as of the date of this release, and are subject to further changes. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of BioHiTech Global, Inc. to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. BioHiTech Global, Inc. assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future in these forward-looking statements, even if new information becomes available in the future. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission ("SEC"). There may be other factors not mentioned above or included in the BioHiTech's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. BioHiTech Global, Inc. assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.
SOURCE BioHiTech Global, Inc.